Home > Healthcare > Pharmaceuticals > Finished Drug Form > Tramadol Drug Market

Tramadol Drug Market Share

  • Report ID: GMI6684
  • Published Date: Sep 2023
  • Report Format: PDF

Tramadol Drug Market Share

The top players in the global tramadol drug market are:

  • Zydus Cadila
  • Purdue Pharma
  • Mankind Pharma Ltd
  • Mundipharma
  • Amneal Pharmaceuticals
  • Par Pharmaceuticals
  • Vertical Pharmaceuticals
  • Grunenthal Group
  • Nippon Shinyaku Co., Ltd.

These companies are implementing several strategies such as collaborations, acquisitions, partnerships, mergers, and product launches to maintain a competitive edge in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Tramadol drug market size was USD 4.5 billion in 2022 and will reach USD 8.6 billion by 2032 due to the rising prevalence of pain disorders, such as arthritis, neuropathy, or fibromyalgia worldwide.

The tablet dosage form segment held 50% share of the tramadol drug industry in 2022 and will witness significant growth from 2023-2032 on account of the precise dosage control of tablets that to allow foroffer consistent and accurate administration of tramadol.

North America recorded 38.6% share of the tramadol drug industry in 2022 and is expected to incur appreciable growth from 2023-2032 owing to the prevalence of pain conditions, including acute and chronic pain among consumers in the region.

Zydus Cadila, Purdue Pharma, Mankind Pharma Ltd, Mundipharma, Amneal Pharmaceuticals, Par Pharmaceuticals, Vertical Pharmaceuticals, Grunenthal Group, and Nippon Shinyaku Co., Ltd. are some of the major tramadol drug companies worldwide.

Tramadol Drug Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 9
  • Tables & Figures: 206
  • Countries covered: 19
  • Pages: 120
 Download Free Sample